Printer Friendly

Just Published: "Age-related Macular Degeneration Partnering 2010-2015".

[USPRwire, Sun May 17 2015] Age-related Macular Degeneration Partnering 2010-2015 report provides understanding and access to the age-related macular degeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

* Trends in age-related macular degeneration partnering deals

* Top age-related macular degeneration deals by value

* Deals listed by company A-Z, industry sector, stage of development, technology type

Age-related Macular Degeneration Partnering 2009-2014 provides understanding and access to the age-related macular degeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

Full Report Details at

- http://www.fastmr.com/prod/994021_agerelated_macular.aspx?afid=302

The report provides an analysis of age-related macular degeneration partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors age-related macular degeneration technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains over 70 links to online copies of actual liver disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of HIV partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in age-related macular degeneration partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading age-related macular degeneration deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Copyright 2015 USPRwire Provided by SyndiGate Media Inc. ( Syndigate.info ).

COPYRIGHT 2015 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:USPRwire
Date:May 17, 2015
Words:403
Previous Article:Television and Radio Receivers, Sound and Video Recording Devices in Canada: Industrial Report.
Next Article:Now Available: Vitamins and Dietary Supplements in Brazil.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters